Details of the Drug Reposition

General Information of This Drug (ID: DMTQIB2)

Drug Name
Anti-MUC1 CAR-T cells   DMTQIB2
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Malignant glioma DISFXKOV 2A00.0 Phase 1/2 [1]
Gastric adenocarcinoma DISWWLTC 2B72 Phase 1/2 [1]
Colorectal cancer DISNH7P9 2B91.Z Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02617134) CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor